UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review

Gynecologic oncology, 2009-02, Vol.112 (2), p.422-436

2009

Volltextzugriff (PDF)

Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers

Obstetrics and gynecology (New York. 1953), 2014-05, Vol.123 (5), p.1031-1037

2014

Volltextzugriff (PDF)

Diagnosis and management of epithelial ovarian cancer

Obstetrics and gynecology (New York. 1953), 2006-06, Vol.107 (6), p.1399-1410

2006

Volltextzugriff (PDF)

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

Gynecologic oncology, 2001-09, Vol.82 (3), p.532-537

2001

Volltextzugriff (PDF)

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

The New England journal of medicine, 1996-12, Vol.335 (26), p.1950-1955

1996

Volltextzugriff (PDF)

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study

Gynecologic oncology, 2009-09, Vol.114 (3), p.472-479

2009

Volltextzugriff (PDF)

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study

Gynecologic oncology, 2009-06, Vol.113 (3), p.341-347

2009

Volltextzugriff (PDF)

Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors

Journal of Oncology, 2014-01, Vol.2014 (2014), p.1-4

2014

Volltextzugriff (PDF)

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4946-4951

2007

Volltextzugriff (PDF)

High Incidence of Positive Peritoneal Cytology in Low-Risk Endometrial Cancer Treated by Laparoscopically Assisted Vaginal Hysterectomy

Gynecologic oncology, 2001-03, Vol.80 (3), p.378-382

2001

Volltextzugriff (PDF)

Impact of hospital volume on operative mortality for major cancer surgery

JAMA : the journal of the American Medical Association, 1998-11, Vol.280 (20), p.1747

1998

Volltextzugriff (PDF)

The key to improving survival in ovarian cancer: better screening of women with vague symptoms, leading to earlier diagnosis, more effective surgery

Oncology (Williston Park, N.Y.), 2013-06, Vol.27 (6), p.C2

Hoskins, William J

2013

Volltextzugriff (PDF)

The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma : A Gynecologic Oncology Group Study

Cancer, 2009-03, Vol.115 (5), p.1028-1035

2009

Volltextzugriff (PDF)

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

The New England journal of medicine, 1996-01, Vol.334 (1), p.1-6

1996

Volltextzugriff (PDF)

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum

Gynecologic oncology, 2010-03, Vol.116 (3), p.351-357

2010

Volltextzugriff (PDF)

John L. Lewis, Jr., MD 1929–2012

Gynecologic oncology, 2013-01, Vol.128 (1), p.146-146

2013

Volltextzugriff (PDF)

How should women with a genetic predisposition for cancer be managed?

Obstetrics and gynecology (New York. 1953), 2007-07, Vol.110 (1), p.5-6

Hoskins, William J

2007

Volltextzugriff (PDF)

Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: Outcomes and impact on approach

Gynecologic oncology, 2012-05, Vol.125 (2), p.394-399

2012

Volltextzugriff (PDF)

Is there a difference in outcome between stage I–II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

International journal of radiation oncology, biology, physics, 2002-09, Vol.54 (1), p.79-85

2002

Volltextzugriff (PDF)

The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

Gynecologic oncology, 2000-05, Vol.77 (2), p.227-231

2000

Volltextzugriff (PDF)

Early Detection Biomarkers for Ovarian Cancer

Journal of Oncology, 2012-01, Vol.2012 (2012), p.1-15

2012

Volltextzugriff (PDF)

Appropriately aggressive management for a rare cancer

Oncology (Williston Park, N.Y.), 2008-09, Vol.22 (10), p.1146

Hoskins, William J

2008

Volltextzugriff (PDF)

Analysis of MLH1 and MSH2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy

Clinical cancer research, 2000-04, Vol.6 (4), p.1415-1421

2000

Volltextzugriff (PDF)

Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up

Journal of clinical oncology, 2002-02, Vol.20 (3), p.694-698

Barakat, R. R.

2002

Volltextzugriff (PDF)

Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings

Obstetrics and gynecology (New York. 1953), 1999-01, Vol.93 (1), p.21-24

1999

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(237)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review

Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers

Diagnosis and management of epithelial ovarian cancer

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study

Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less

High Incidence of Positive Peritoneal Cytology in Low-Risk Endometrial Cancer Treated by Laparoscopically Assisted Vaginal Hysterectomy

Impact of hospital volume on operative mortality for major cancer surgery

The key to improving survival in ovarian cancer: better screening of women with vague symptoms, leading to earlier diagnosis, more effective surgery

The Prognostic Value of Pretreatment CA 125 in Patients With Advanced Ovarian Carcinoma : A Gynecologic Oncology Group Study

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum

John L. Lewis, Jr., MD 1929–2012

How should women with a genetic predisposition for cancer be managed?

Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: Outcomes and impact on approach

Is there a difference in outcome between stage I–II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

Early Detection Biomarkers for Ovarian Cancer

Appropriately aggressive management for a rare cancer

Analysis of MLH1 and MSH2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy

Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up

Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings

Suchergebnisse filtern